ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms of LYL1-associated T-ALL development||Baylor College of Medicine / Margaret Goodell, PhD||Innovation Grants||2012||Texas|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|
|Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors||University of Miami Miller School of Medicine / David Robbins, PhD||Innovation Grants||2012||Florida|
|Childhood Leukemia in Kenya Identified Through Malaria Slide Review||Indiana University / Terry Vik||Epidemiology Grants||2012||Indiana|
|Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database||Huntsman Cancer Institute / Joshua Schiffman, MD||Epidemiology Grants||2012||Utah|
|Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research||Washington University / Kimberly Johnson Ph.D.||Epidemiology Grants||2012||Missouri|
|Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia||Washington University / Grant Challen, PhD||'A' Award Grants||2012||Missouri|
|A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Myron Ignatius, PhD||'A' Award Grants||2012||Massachusetts|
|BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia||Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD||'A' Award Grants||2012||New York|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|